Predictors of Significant Disease Activity Score-28 (Using C-reactive protein) Remission Achieved with Intravenous Golimumab in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Trial

被引：0

作者：

Bingham, Clifton O., III ^{[1
]}

Weinblatt, Michael ^{[2
]}

Mendelsohn, Alan ^{[3
]}

Kim, Lilianne ^{[3
]}

Mack, Michael ^{[3
]}

Lu, Jiandong ^{[3
]}

Baker, Daniel ^{[3
]}

Westhovens, Rene ^{[4
]}

机构：

[1] Johns Hopkins Univ, Baltimore, MD USA

[2] Brigham & Womens Hosp, Boston, MA 02115 USA

[3] Janssen Res & Dev LLC, Spring House, PA USA

[4] Univ Hosp KU Leuven, Louvain, Belgium

来源：

ARTHRITIS AND RHEUMATISM | 2012年 / 64卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1301

引用

页码：S558 / S558

页数：1

共 50 条

[11] Safety and Efficacy Of Subcutaneous Golimumab In Chinese Patients With Active Rheumatoid Arthritis Despite MTX Therapy: Results From a Randomized, Placebo-Controlled, Phase 3 Trial
Li, Zhanguo
Zhang, Fengchun
Kay, Jonathan
Fei, Kaiyin
Han, Chenglong
Zhuang, Yanli
Wu, Zhong
Hsia, Elizabeth C.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S598 - S599
[12] SAFETY AND EFFICACY OF SUBCUTANEOUS GOLIMUMAB IN CHINESE PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE MTX THERAPY: RESULTS FROM A RANDOMIZED, PLACEBO-CONTROLLED, PHASE 3 TRIAL
Li, Z.
Zhang, F.
Kay, J.
Fei, K.
Han, C.
Zhuang, Y.
Wu, Z.
Hsia, E. C.
ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 444 - 444
[13] Radiographic benefit and maintenance of clinical benefit with intravenous golimumab therapy in patients with active rheumatoid arthritis despite methotrexate therapy: results up to 1 year of the phase 3, randomised, multicentre, double blind, placebo controlled GO-FURTHER trial
Weinblatt, Michael E.
Westhovens, Rene
Mendelsohn, Alan M.
Kim, Lilianne
Lo, Kim Hung
Sheng, Shihong
Noonan, Lenore
Lu, Jiandong
Xu, Zhenhua
Leu, Jocelyn
Baker, Daniel
Bingham, Clifton O.
ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (12) : 2152 - 2159
[14] Final 5-Year Safety and Efficacy Results Of a Phase 3, Randomized Placebo-Controlled Trial Of Golimumab In Patients With Active Rheumatoid Arthritis Despite Prior Treatment With Methotrexate
Keystone, Edward
Genovese, Mark C.
Hall, Stephen
Miranda, Pedro
Bae, Sang-Cheol
Han, Chenglong
Gathany, Timothy A.
Zhou, Yiying
Xu, Stephen
Hsia, Elizabeth C.
ARTHRITIS AND RHEUMATISM, 2013, 65 : S597 - S598
[15] Effects of high dose intravenous pamidronate on disease activity and bone metabolism in patients with active rheumatoid arthritis: A randomized, double-blind, placebo-controlled trial
Lodder, MC
Van Pelt, PA
Lems, WF
Kostense, PJ
Koks, CHW
Dijkmans, BAC
JOURNAL OF RHEUMATOLOGY, 2003, 30 (09) : 2080 - 2082
[16] Maintenance of Clinical and Radiographic Benefit With Intravenous Golimumab Therapy in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy: Week-112 Efficacy and Safety Results of the Open-Label Long-Term Extension of a Phase III, Double-Blind, Randomized, Placebo-Controlled Trial
Bingham, Clifton O., III
Mendelsohn, Alan M.
Kim, Lilianne
Xu, Zhenhua
Leu, Jocelyn
Han, Chenglong
Lo, Kim Hung
Westhovens, Rene
Weinblatt, Michael E.
ARTHRITIS CARE & RESEARCH, 2015, 67 (12) : 1627 - 1636
[17] Golimumab administered subcutaneously every 4 wks in patients with active rheumatoid arthritis despite methotrexate: Wk 24 results of the randomized, double-blind, placebo-controlled, GO-FORWARD study
Keystone, E.
Genovese, M. C.
Klareskog, L.
Hsia, E. C.
Livingston, J.
Wiekowski, M.
Hall, S. T.
Miranda, P.
Pazdur, J.
Bae, S. C.
Palmer, W.
Wu, Z.
Rahman, M. U.
ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S618 - S619
[18] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-Blind, Placebo-Controlled Psummit I Study
Kavanaugh, Arthur
McInnes, Iain B.
Gottlieb, Alice B.
Puig, Lluis
Rahman, Proton
Ritchlin, Christopher T.
Li, Shu
Wang, Yuhua
Mendelsohn, Alan
Doyle, Mittie K.
ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S1083 - S1084
[19] Ustekinumab in Patients with Active Psoriatic Arthritis: Results of the Phase 3, Multicenter, Double-blind, Placebo-Controlled PSUMMIT I Study
Rahman, Proton
Kavanaugh, Arthur
Gottlieb, Alice
Puig, Lluis
Ritchlin, Christopher
McInnes, Iain
Li, Shu
Wang, Yuhua
Mendelsohn, Alan
Doyle, Mittie
JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 983 - 983
[20] FINAL 5-YEAR SAFETY AND EFFICACY RESULTS OF A PHASE 3, RANDOMIZED PLACEBO-CONTROLLED TRIAL OF GOLIMUMAB IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS DESPITE
Keystone, Edward
Genovese, Mark C.
Hall, Stephen
Miranda, Pedro C.
Bae, Sang-Cheol
Han, Chenglong
Gathany, Tim
Zhou, Yiying
Xu, Stephen
Hsia, Elizabeth C.
RHEUMATOLOGY, 2014, 53 : 99 - 99

← 1 2 3 4 5 →